Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oncopeptides Major Shareholding Notification 2018

Mar 23, 2018

3091_iss_2018-03-23_e3bf9830-0b87-4376-b6f9-3e33f71a6999.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Oncopeptides AB

Holder

Stiftelsen Industrifonden

Instrument

Instrument Ordinary shares SE0009414576
Before the transaction
Shares Data not given*
Voting rights Data not given*
Transaction
Reason for major shareholding notification Share loan
Date 22/03/2018
Limit for number of shares 20 %
Limit for number of votes 20 %
After the transaction
Quantity
Shares 7,640,805
Directly held voting rights 7,640,805
Indirectly held voting rights 0
Percentage
Directly held shares 19.1951 %
Directly held voting rights 19.1951 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 19.1951 % 7,640,805
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
9.99849 % 3,980,000
- Physically settled
- Cash settled
Total 29.19359 % 11,620,805

Group total holdings

Voting rights 11,620,805 Percentage of voting rights 29.19359

Notes (other relevant informations according to law)

Flaggningen avser utlån av aktier i samband med nyemission i Oncopeptides. Flaggningen är baserad på 39 806 021 utestående aktier i Oncopeptides per den 22 mars 2018, dagen då flaggningsskyldigheten uppstod.

Published

23/03/2018 13:49

Contact

Name Jonas Brambeck

Phone +46708791937 Email [email protected]

*Source of information has chosen not to submit the data

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25